MedTrace Logo

Simvastatin in Patients With Isolated Arterial Hypertension

NCT01017835 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2009-11-23

No results posted yet for this study

Summary

The purpose of this study is to determine whether combined therapy with simvastatin and hypotensive drugs (ACEI or ARB) may decrease the blood pressure. Moreover, we would like to assess the influence of isolated hypertension on endothelial injury, and on the development of atherosclerosis.

Conditions

Sponsors & Collaborators

  • Medical University of Lodz

    lead OTHER

Principal Investigators

  • Maciej Banach, MD PhD · Departament of Hypertension , Medical University of Lodz

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2011-06-30
Completion
2012-01-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01017835 on ClinicalTrials.gov